CA2964782C - Compositions pharmaceutiques comprenant des variants de peptide et leurs procedes d'utilisation - Google Patents

Compositions pharmaceutiques comprenant des variants de peptide et leurs procedes d'utilisation

Info

Publication number
CA2964782C
CA2964782C CA2964782A CA2964782A CA2964782C CA 2964782 C CA2964782 C CA 2964782C CA 2964782 A CA2964782 A CA 2964782A CA 2964782 A CA2964782 A CA 2964782A CA 2964782 C CA2964782 C CA 2964782C
Authority
CA
Canada
Prior art keywords
seq
pharmaceutical composition
peptide
amino acid
fgf19
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2964782A
Other languages
English (en)
Other versions
CA2964782A1 (fr
Inventor
Darrin Anthony Lindhout
Charles V. Olson
Original Assignee
NGM Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NGM Biopharmaceuticals Inc filed Critical NGM Biopharmaceuticals Inc
Priority claimed from PCT/US2015/056830 external-priority patent/WO2016065106A1/fr
Publication of CA2964782A1 publication Critical patent/CA2964782A1/fr
Application granted granted Critical
Publication of CA2964782C publication Critical patent/CA2964782C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des compositions pharmaceutiques, des formulations et des formes posologiques comportant des variants des protéines du facteur de croissance des fibroblastes 19 (FGF19) et des séquences peptidiques (et peptidomimétiques) et des fusions de FGF19, et/ou des protéines du facteur de croissance des fibroblastes 21 (FGF21) et des séquences peptidiques (et peptidomimétiques), et des variants de fusions de protéines de FGF19 et/ou de FGF21 et de leurs séquences peptidiques (et peptidomimétiques). L'invention concerne également des procédés d'utilisation des compositions pharmaceutiques, des formulations et des formes posologiques.
CA2964782A 2014-10-23 2015-10-22 Compositions pharmaceutiques comprenant des variants de peptide et leurs procedes d'utilisation Active CA2964782C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462067824P 2014-10-23 2014-10-23
US62/067,824 2014-10-23
PCT/US2015/056830 WO2016065106A1 (fr) 2014-10-23 2015-10-22 Compositions pharmaceutiques comprenant des variants de peptide et leurs procédés d'utilisation

Publications (2)

Publication Number Publication Date
CA2964782A1 CA2964782A1 (fr) 2016-04-28
CA2964782C true CA2964782C (fr) 2025-09-09

Family

ID=

Similar Documents

Publication Publication Date Title
US20220047675A1 (en) Pharmaceutical compositions comprising peptide variants and methods of use thereof
AU2012279237B2 (en) Compositions, uses and methods for treatment of metabolic disorders and diseases
US20200390859A1 (en) Methods for treatment of bile acid-related disorders
US9963494B2 (en) Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject
US20220072099A1 (en) Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders
US20140194352A1 (en) Compositions and Methods for Treatment of Metabolic Disorders and Diseases
EP3155005A2 (fr) Procédés et utilisations pour la modulation de l'homéostasie de l'acide biliaire et le traitement de troubles et maladies de l'acide biliaire
US20200330555A1 (en) Methods of treating gastrointestinal motility-related disorders using variants and fusions of fgf19/fgf21 polypeptides
CA2964782C (fr) Compositions pharmaceutiques comprenant des variants de peptide et leurs procedes d'utilisation
WO2021092140A1 (fr) Méthodes de réduction du lactate chez des patients malades du foie au moyen de variants et de fusions de polypeptides fgf19/fgf21
HK40015656A (en) Compositions, uses and methods for treatment of metabolic disorders and diseases
BR112017007816B1 (pt) Composições farmacêuticas e uso das mesmas